Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease
NCT02021110
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Polycystic Liver Disease
Polycystic Kidney, Autosomal Dominant
Interventions
DRUG:
Ursodeoxycholic Acid
Sponsor
Radboud University Medical Center
Collaborators
[object Object]